Phibro Animal Health (PAHC) Change in Receivables (2013 - 2026)

Phibro Animal Health's Change in Receivables history runs 14 years deep, the most recent figure standing at $4.8 million for Q1 2026.

• On a quarterly basis, Change in Receivables rose 37.64% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $17.0 million, a 58.43% decrease from a year earlier, with the FY2025 full-year figure at $55.2 million, up 536.18% from the prior year.
• Change in Receivables climbed to $4.8 million in Q1 2026 per PAHC's latest filing, from -$2.3 million in the prior quarter.
• Across five years, Change in Receivables topped out at $35.0 million in Q4 2024 and bottomed at -$22.3 million in Q3 2022.
• The 5-year median for Change in Receivables is $4.8 million (2026), against an average of $4.4 million.
• Across the five-year window, Change in Receivables tumbled 411.02% in 2022 and jumped 7819.86% in 2024, its largest moves.
• Year by year, Change in Receivables stood at $7.5 million in 2022, then sank by 120.44% to -$1.5 million in 2023, then surged by 2379.41% to $35.0 million in 2024, then plunged by 106.67% to -$2.3 million in 2025, then surged by 304.71% to $4.8 million in 2026.
• Per Business Quant, the three latest PAHC Change in Receivables figures stand at $4.8 million (Q1 2026), -$2.3 million (Q4 2025), and -$11.4 million (Q3 2025).